Mithridion
Madison
About Mithridion
Mithridion is a biopharmaceutical company that discovers and develops drugs for central nervous system disorders, with an initial focus on Alzheimer's disease and schizophrenia.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $6.4M
- Funding stage: Late Stage Venture
- Last round: Series C (Jan 2011)
- Website: mithridion.com
- Phone: +1 4087800908
Industries & Categories
Biotechnology, Medical, Therapeutics
Canonical: https://fsome.com/organization/mithridion-2950761 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.